- Home
- LRMR vs CLCO Comparison
LRMR vs CLCO Comparison
Compare LRMR & CLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- CLCO
- Stock Information
- Founded
- LRMR N/A
- CLCO 2018
- Country
- LRMR United States
- CLCO United Kingdom
- Employees
- LRMR N/A
- CLCO N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- CLCO
- Sector
- LRMR Health Care
- CLCO
- Exchange
- LRMR Nasdaq
- CLCO Nasdaq
- Market Cap
- LRMR 426.9M
- CLCO 417.5M
- IPO Year
- LRMR N/A
- CLCO N/A
- Fundamental
- Price
- LRMR $3.34
- CLCO $8.57
- Analyst Decision
- LRMR Strong Buy
- CLCO
- Analyst Count
- LRMR 8
- CLCO 0
- Target Price
- LRMR $19.63
- CLCO N/A
- AVG Volume (30 Days)
- LRMR 678.8K
- CLCO 188.9K
- Earning Date
- LRMR 03-13-2025
- CLCO 02-26-2025
- Dividend Yield
- LRMR N/A
- CLCO 7.00%
- EPS Growth
- LRMR N/A
- CLCO N/A
- EPS
- LRMR N/A
- CLCO 1.73
- Revenue
- LRMR N/A
- CLCO $333,653,000.00
- Revenue This Year
- LRMR N/A
- CLCO N/A
- Revenue Next Year
- LRMR N/A
- CLCO $2.93
- P/E Ratio
- LRMR N/A
- CLCO $5.10
- Revenue Growth
- LRMR N/A
- CLCO N/A
- 52 Week Low
- LRMR $3.01
- CLCO $6.92
- 52 Week High
- LRMR $13.68
- CLCO $13.68
- Technical
- Relative Strength Index (RSI)
- LRMR 29.00
- CLCO 55.52
- Support Level
- LRMR $3.24
- CLCO $8.34
- Resistance Level
- LRMR $3.54
- CLCO $9.02
- Average True Range (ATR)
- LRMR 0.22
- CLCO 0.27
- MACD
- LRMR 0.03
- CLCO 0.14
- Stochastic Oscillator
- LRMR 12.26
- CLCO 68.31
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements.